2013 Q4 Form 10-Q Financial Statement
#000114519713000035 Filed on November 07, 2013
Income Statement
Concept | 2013 Q4 | 2013 Q3 | 2012 Q3 |
---|---|---|---|
Revenue | $68.53M | $61.10M | $54.75M |
YoY Change | 18.51% | 11.6% | 22.78% |
Cost Of Revenue | $35.50M | $33.71M | $30.36M |
YoY Change | 9.23% | 11.02% | 16.63% |
Gross Profit | $33.02M | $27.40M | $24.39M |
YoY Change | 30.41% | 12.32% | 31.4% |
Gross Profit Margin | 48.18% | 44.83% | 44.55% |
Selling, General & Admin | $26.40M | $38.94M | $26.30M |
YoY Change | 3.13% | 48.04% | 11.02% |
% of Gross Profit | 79.96% | 142.13% | 107.84% |
Research & Development | $6.400M | $5.771M | $6.559M |
YoY Change | 10.34% | -12.01% | 41.42% |
% of Gross Profit | 19.38% | 21.07% | 26.89% |
Depreciation & Amortization | $2.950M | $3.100M | $2.590M |
YoY Change | 0.34% | 19.69% | -8.48% |
% of Gross Profit | 8.93% | 11.32% | 10.62% |
Operating Expenses | $32.80M | $44.71M | $32.86M |
YoY Change | 4.46% | 36.05% | 16.0% |
Operating Profit | $218.0K | -$17.31M | -$8.471M |
YoY Change | -103.58% | 104.38% | -13.28% |
Interest Expense | -$2.900M | $100.0K | -$3.900M |
YoY Change | -27.5% | -102.56% | 2.63% |
% of Operating Profit | -1330.28% | ||
Other Income/Expense, Net | -$3.972M | -$3.918M | |
YoY Change | 1.38% | 3.27% | |
Pretax Income | -$2.700M | -$21.29M | -$12.39M |
YoY Change | -73.27% | 71.81% | -8.65% |
Income Tax | -$200.0K | $5.000K | $28.00K |
% Of Pretax Income | |||
Net Earnings | -$2.500M | -$21.29M | -$12.42M |
YoY Change | -75.48% | 71.46% | -8.44% |
Net Earnings / Revenue | -3.65% | -34.84% | -22.68% |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$45.70K | -$390.8K | -$258.3K |
COMMON SHARES | |||
Basic Shares Outstanding | 54.54M shares | 54.42M shares | 47.99M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2013 Q4 | 2013 Q3 | 2012 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $149.7M | $153.9M | $63.40M |
YoY Change | 161.26% | 142.74% | -38.92% |
Cash & Equivalents | $149.7M | $153.9M | $63.44M |
Short-Term Investments | |||
Other Short-Term Assets | $5.900M | $5.900M | $5.600M |
YoY Change | 31.11% | 5.36% | 51.35% |
Inventory | $9.464M | $5.395M | $15.09M |
Prepaid Expenses | |||
Receivables | $33.07M | $34.47M | $30.15M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $198.2M | $199.7M | $114.2M |
YoY Change | 80.28% | 74.79% | -17.86% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $32.36M | $31.40M | $24.91M |
YoY Change | 27.28% | 26.05% | 36.12% |
Goodwill | $37.40M | $37.54M | $37.54M |
YoY Change | -0.37% | 0.0% | 0.09% |
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $1.825M | $1.721M | $2.333M |
YoY Change | -17.12% | -26.23% | -16.68% |
Total Long-Term Assets | $89.76M | $89.81M | $89.14M |
YoY Change | 1.85% | 0.76% | -0.14% |
TOTAL ASSETS | |||
Total Short-Term Assets | $198.2M | $199.7M | $114.2M |
Total Long-Term Assets | $89.76M | $89.81M | $89.14M |
Total Assets | $288.0M | $289.5M | $203.4M |
YoY Change | 45.39% | 42.34% | -10.93% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $19.36M | $15.12M | $16.22M |
YoY Change | 106.8% | -6.78% | 88.56% |
Accrued Expenses | $19.48M | $30.02M | $17.82M |
YoY Change | 2.24% | 68.48% | 39.19% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $0.00 | $0.00 | $14.13M |
YoY Change | -100.0% | -100.0% | |
Total Short-Term Liabilities | $42.37M | $48.29M | $49.34M |
YoY Change | -12.24% | -2.12% | 98.96% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $113.7M | $111.1M | $101.5M |
YoY Change | 9.56% | 9.46% | -4.5% |
Other Long-Term Liabilities | $1.943M | $2.567M | $2.070M |
YoY Change | 4.07% | 24.01% | -16.57% |
Total Long-Term Liabilities | $115.6M | $113.7M | $103.6M |
YoY Change | 9.47% | 9.75% | 4075.21% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $42.37M | $48.29M | $49.34M |
Total Long-Term Liabilities | $115.6M | $113.7M | $103.6M |
Total Liabilities | $163.4M | $168.1M | $152.9M |
YoY Change | 6.16% | 9.9% | 14.5% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$526.5M | -$524.0M | -$471.4M |
YoY Change | 9.34% | 11.17% | 13.49% |
Common Stock | $55.00K | $55.00K | $48.00K |
YoY Change | 14.58% | 14.58% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $124.6M | $121.4M | $50.45M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $288.0M | $289.5M | $203.4M |
YoY Change | 45.39% | 42.34% | -10.93% |
Cashflow Statement
Concept | 2013 Q4 | 2013 Q3 | 2012 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$2.500M | -$21.29M | -$12.42M |
YoY Change | -75.48% | 71.46% | -8.44% |
Depreciation, Depletion And Amortization | $2.950M | $3.100M | $2.590M |
YoY Change | 0.34% | 19.69% | -8.48% |
Cash From Operating Activities | -$3.520M | $3.700M | -$3.450M |
YoY Change | -37.03% | -207.25% | 315.66% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$2.790M | -$1.820M | -$4.690M |
YoY Change | 36.1% | -61.19% | 42.99% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | $0.00 | |
YoY Change | |||
Cash From Investing Activities | -$2.790M | -$1.820M | -$4.690M |
YoY Change | 36.1% | -61.19% | 43.43% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 2.130M | 1.090M | 1.430M |
YoY Change | 42.0% | -23.78% | 21.19% |
NET CHANGE | |||
Cash From Operating Activities | -3.520M | 3.700M | -3.450M |
Cash From Investing Activities | -2.790M | -1.820M | -4.690M |
Cash From Financing Activities | 2.130M | 1.090M | 1.430M |
Net Change In Cash | -4.180M | 2.970M | -6.710M |
YoY Change | -31.92% | -144.26% | 129.79% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$3.520M | $3.700M | -$3.450M |
Capital Expenditures | -$2.790M | -$1.820M | -$4.690M |
Free Cash Flow | -$730.0K | $5.520M | $1.240M |
YoY Change | -79.38% | 345.16% | -49.39% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2013Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
15117000 | USD |
CY2012Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
9361000 | USD |
CY2012Q4 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
39921000 | USD |
CY2013Q3 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
41762000 | USD |
CY2012Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
33294000 | USD |
CY2013Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
34465000 | USD |
CY2012Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
19051000 | USD |
CY2013Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
30017000 | USD |
us-gaap |
Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
|
P8Y | ||
us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
83000 | USD | |
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
7111000 | USD | |
CY2012Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
525679000 | USD |
CY2013Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
645396000 | USD |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
7500000 | USD | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
9800000 | USD | |
CY2013Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3000000 | USD |
CY2012Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2300000 | USD |
CY2012Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
6627000 | USD |
CY2013Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
7297000 | USD |
CY2013Q3 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
2447000 | USD |
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
7958000 | USD | |
CY2012Q3 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
2420000 | USD |
CY2013Q3 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
146000 | USD |
us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
445000 | USD | |
us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
443000 | USD | |
CY2012Q3 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
148000 | USD |
us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
7556000 | USD | |
us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
8726000 | USD | |
CY2012Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1400000 | USD |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
3800000 | USD | |
CY2013Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1100000 | USD |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
4600000 | USD | |
CY2013Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
8715231 | shares |
CY2012Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
9810682 | shares |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
8715231 | shares | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
9810682 | shares | |
CY2012Q4 | us-gaap |
Assets
Assets
|
198059000 | USD |
CY2013Q3 | us-gaap |
Assets
Assets
|
289496000 | USD |
CY2012Q4 | us-gaap |
Assets Current
AssetsCurrent
|
109936000 | USD |
CY2013Q3 | us-gaap |
Assets Current
AssetsCurrent
|
199686000 | USD |
CY2013Q3 | us-gaap |
Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
|
2593000 | USD |
CY2012Q4 | us-gaap |
Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
|
0 | USD |
us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
0 | USD | |
us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
9021000 | USD | |
CY2012Q4 | us-gaap |
Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
|
0 | USD |
CY2013Q3 | us-gaap |
Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
|
6092000 | USD |
CY2013Q3 | us-gaap |
Capital Leased Assets Gross
CapitalLeasedAssetsGross
|
6500000 | USD |
CY2013Q3 | us-gaap |
Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
|
10993000 | USD |
CY2013Q3 | us-gaap |
Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
|
3815000 | USD |
CY2013Q2 | us-gaap |
Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
|
26523 | shares |
CY2013Q3 | us-gaap |
Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
|
2409000 | USD |
CY2013Q3 | us-gaap |
Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
|
3815000 | USD |
CY2013Q3 | us-gaap |
Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
|
954000 | USD |
CY2013Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
153905000 | USD |
CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
57293000 | USD |
CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
93955000 | USD |
CY2012Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
63443000 | USD |
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
96612000 | USD | |
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-30512000 | USD | |
CY2012Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2013Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2012Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2013Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2012Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2013Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2013Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
54521310 | shares |
CY2012Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
48359063 | shares |
CY2013Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
54521310 | shares |
CY2012Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
48359063 | shares |
CY2013Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
55000 | USD |
CY2012Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
48000 | USD |
CY2012 | us-gaap |
Concentration Risk Percentage1
ConcentrationRiskPercentage1
|
0.19 | |
us-gaap |
Concentration Risk Percentage1
ConcentrationRiskPercentage1
|
0.26 | ||
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
99168000 | USD | |
CY2013Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
33708000 | USD |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
86524000 | USD | |
CY2012Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
30362000 | USD |
us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
171000 | USD | |
CY2013Q3 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
-20000 | USD |
CY2012Q3 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
15000 | USD |
us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
78000 | USD | |
us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
700000 | USD | |
us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
18000 | USD | |
us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
65000 | USD | |
CY2013Q2 | us-gaap |
Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
|
620122 | shares |
CY2013Q3 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
32633000 | USD |
CY2012Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
40591000 | USD |
CY2013Q3 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
1560000 | USD |
CY2012Q4 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
2004000 | USD |
CY2012Q3 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
13000 | USD |
CY2013Q3 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
25000 | USD |
CY2012Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
5400000 | USD |
CY2013Q3 | us-gaap |
Deferred Revenue
DeferredRevenue
|
600000 | USD |
CY2013Q3 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
567000 | USD |
CY2012Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
5445000 | USD |
CY2013Q3 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
500000 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
500000 | USD |
CY2013Q3 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
800000 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
700000 | USD |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
8859000 | USD | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
8092000 | USD | |
CY2013Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.39 | |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.79 | ||
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.87 | ||
CY2012Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.26 | |
CY2013Q3 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
26600000 | USD |
CY2013Q3 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
13746000 | USD |
CY2012Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
9937000 | USD |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1966000 | USD | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1401000 | USD | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
7500000 | USD | |
CY2013Q3 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
32900000 | USD |
CY2012Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
32900000 | USD |
CY2012Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
22963000 | USD |
CY2013Q3 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
19154000 | USD |
CY2011 | us-gaap |
Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
|
32900000 | USD |
CY2012Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
12731000 | USD |
CY2013Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
23530000 | USD |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
38416000 | USD | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
50525000 | USD | |
CY2013Q3 | us-gaap |
Goodwill
Goodwill
|
37536000 | USD |
CY2012Q4 | us-gaap |
Goodwill
Goodwill
|
37536000 | USD |
us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | USD | |
CY2013Q3 | us-gaap |
Gross Profit
GrossProfit
|
27395000 | USD |
CY2012Q3 | us-gaap |
Gross Profit
GrossProfit
|
24390000 | USD |
us-gaap |
Gross Profit
GrossProfit
|
79383000 | USD | |
us-gaap |
Gross Profit
GrossProfit
|
67017000 | USD | |
us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | USD | |
CY2013Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-21285000 | USD |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-41530000 | USD | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-42220000 | USD | |
CY2012Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-12389000 | USD |
CY2012Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
28000 | USD |
CY2013Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
5000 | USD |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
254000 | USD | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
143000 | USD | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
3251000 | USD | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
9276000 | USD | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
5113000 | USD | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-4878000 | USD | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-1444000 | USD | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-9472000 | USD | |
us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
12970000 | USD | |
CY2013Q3 | us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
3999000 | USD |
us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
11728000 | USD | |
CY2012Q3 | us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
3949000 | USD |
CY2013Q3 | us-gaap |
Interest Expense
InterestExpense
|
100000 | USD |
us-gaap |
Interest Expense
InterestExpense
|
100000 | USD | |
us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
12203000 | USD | |
CY2013Q3 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
3940000 | USD |
us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
13082000 | USD | |
CY2012Q3 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
4117000 | USD |
CY2012Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
11785000 | USD |
CY2013Q3 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
5068000 | USD |
CY2013Q3 | us-gaap |
Inventory Net
InventoryNet
|
5395000 | USD |
CY2012Q4 | us-gaap |
Inventory Net
InventoryNet
|
14867000 | USD |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
10.30 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
19.36 | ||
CY2012Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
198059000 | USD |
CY2013Q3 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
321000 | USD |
CY2012Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
1487000 | USD |
CY2012Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
1595000 | USD |
CY2013Q3 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
6000 | USD |
CY2012Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
31000 | USD |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
83000 | USD | |
CY2013Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
27000 | USD |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
91000 | USD | |
CY2013Q3 | us-gaap |
Liabilities
Liabilities
|
168070000 | USD |
CY2012Q4 | us-gaap |
Liabilities
Liabilities
|
153883000 | USD |
CY2013Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
289496000 | USD |
CY2012Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
48286000 | USD |
CY2013Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
48294000 | USD |
CY2012Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
118159000 | USD |
CY2013Q3 | us-gaap |
Long Term Debt
LongTermDebt
|
111117000 | USD |
CY2013Q3 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
0 | USD |
CY2012Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
14429000 | USD |
CY2012Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
103730000 | USD |
CY2013Q3 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
111117000 | USD |
us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nature of the Business</font></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is primarily engaged in the development, manufacturing and sale of its proprietary OmniPod Insulin Management System (the “OmniPod System”), an innovative, discreet and easy-to-use insulin infusion system for people with insulin-dependent diabetes. The OmniPod System is the only commercially-available insulin infusion system of its kind. The OmniPod System features a unique disposable tubeless OmniPod which is worn on the body for approximately three days at a time and the handheld, wireless Personal Diabetes Manager (“PDM”). Conventional insulin pumps require people with insulin-dependent diabetes to learn to use, manage and wear a number of cumbersome components, including up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">42</font><font style="font-family:inherit;font-size:10pt;"> inches of tubing. In contrast, the OmniPod System features two discreet, easy-to-use devices that eliminate the need for a bulky pump, tubing and separate blood glucose meter, provides for virtually pain-free automated cannula insertion, communicates wirelessly and integrates a blood glucose meter. </font></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2011, the Company acquired Neighborhood Holdings, Inc. and its wholly-owned subsidiaries (collectively, “Neighborhood Diabetes”) in order to support the sales of the OmniPod System, expand the Company’s full suite diabetes management product offerings and obtain access to a larger number of insulin dependent patients. Through Neighborhood Diabetes, the Company is able to provide customers with blood glucose testing supplies, traditional insulin pumps, pump supplies and pharmaceuticals and has the ability to process claims as either durable medical equipment or through pharmacy benefits.</font></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company began commercial sale of the OmniPod System in the United States in October 2005. The Company has also expanded the availability of the OmniPod System internationally through its partnership with Ypsomed Distribution AG (“Ypsomed”) and GlaxoSmithKline (“GSK”). In January 2010, the Company entered into a distribution agreement with Ypsomed pursuant to which Ypsomed became the exclusive distributor of the OmniPod System in multiple countries. In February 2011, the Company entered into a distribution agreement with GSK pursuant to which GSK became the exclusive distributor of the OmniPod System in Canada. </font></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2011, the Company received CE Mark approval, and in December 2012 the Company received 510(k) clearance by the FDA for its new OmniPod System. The new OmniPod System is more than one-third smaller and one-quarter lighter than the original model, while maintaining the same features and operating capabilities. The Company began selling the new OmniPod System in certain countries in Europe through Ypsomed in 2012. The Company began selling the new OmniPod System to new customers in the U.S. during the first quarter of 2013 and began converting the existing customer base in the second quarter of 2013. By the end of the third quarter, the Company completely transitioned its production to the new OmniPod System.</font></div></div> | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1890000 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
94263000 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-4517000 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-8936000 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-23466000 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
6866000 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-42474000 | USD | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
25.54 | ||
us-gaap |
Operating Expenses
OperatingExpenses
|
96902000 | USD | |
CY2013Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
44708000 | USD |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-29885000 | USD | |
CY2013Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-17313000 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-41673000 | USD | |
CY2012Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-12417000 | USD |
CY2013Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-21290000 | USD |
us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | segment | |
CY2012Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
32861000 | USD |
us-gaap |
Operating Expenses
OperatingExpenses
|
108724000 | USD | |
CY2012Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8471000 | USD |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-29341000 | USD | |
CY2013Q3 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
1591000 | USD |
CY2013Q3 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
1134000 | USD |
CY2013Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
96000 | USD |
CY2013Q3 | us-gaap |
Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
|
361000 | USD |
us-gaap |
Other Asset Impairment Charges
OtherAssetImpairmentCharges
|
0 | USD | |
us-gaap |
Other Asset Impairment Charges
OtherAssetImpairmentCharges
|
2511000 | USD | |
CY2013Q3 | us-gaap |
Other Asset Impairment Charges
OtherAssetImpairmentCharges
|
2511000 | USD |
CY2012Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
2202000 | USD |
CY2013Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
1721000 | USD |
CY2013Q3 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
2567000 | USD |
CY2012Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
1867000 | USD |
CY2012Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-3918000 | USD |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-11645000 | USD | |
CY2013Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-3972000 | USD |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-12879000 | USD | |
us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
1252000 | USD | |
us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
2565000 | USD | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
4517000 | USD | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
8936000 | USD | |
CY2013Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2012Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2012Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2013Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2012Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2013Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2013Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2012Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2012Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2013Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2012Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
4482000 | USD |
CY2013Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
5921000 | USD |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
99164000 | USD | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
3142000 | USD | |
CY2013Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
97800000 | USD |
CY2012Q4 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
1992000 | USD |
CY2013Q3 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
2809000 | USD |
CY2013Q2 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
2401000 | USD |
CY2012Q3 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
1806000 | USD |
CY2011Q4 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
1960000 | USD |
CY2012Q2 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
1822000 | USD |
CY2012Q4 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
863000 | USD |
CY2013Q3 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
1047000 | USD |
CY2013Q3 | us-gaap |
Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
|
1762000 | USD |
CY2012Q4 | us-gaap |
Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
|
1129000 | USD |
CY2012Q3 | us-gaap |
Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
|
661000 | USD |
us-gaap |
Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
|
2021000 | USD | |
CY2013Q3 | us-gaap |
Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
|
702000 | USD |
us-gaap |
Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
|
1954000 | USD | |
us-gaap |
Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
|
1867000 | USD | |
CY2012Q3 | us-gaap |
Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
|
645000 | USD |
CY2013Q3 | us-gaap |
Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
|
1110000 | USD |
us-gaap |
Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
|
2771000 | USD | |
CY2013Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
31399000 | USD |
CY2012Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
25422000 | USD |
us-gaap |
Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
|
P5Y | ||
us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
3942000 | USD | |
us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
2321000 | USD | |
us-gaap |
Repayments Of Debt
RepaymentsOfDebt
|
0 | USD | |
us-gaap |
Repayments Of Debt
RepaymentsOfDebt
|
2000000 | USD | |
us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
0 | USD | |
us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
336000 | USD | |
CY2013Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5771000 | USD |
CY2012Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
6559000 | USD |
dei |
Document Type
DocumentType
|
10-Q | ||
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
15341000 | USD | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
18512000 | USD | |
CY2012Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-481551000 | USD |
CY2013Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-524025000 | USD |
CY2013Q1 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
20.75 | |
CY2013Q3 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
61103000 | USD |
us-gaap |
Sales Revenue Net
SalesRevenueNet
|
153541000 | USD | |
CY2012Q3 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
54752000 | USD |
us-gaap |
Sales Revenue Net
SalesRevenueNet
|
178551000 | USD | |
CY2013Q3 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
15407000 | USD |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
42858000 | USD | |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
39974000 | USD | |
CY2012Q3 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
13571000 | USD |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
9800000 | USD | |
CY2007Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
535000 | shares |
CY2013Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
1302995 | shares |
CY2013Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
12.70 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
10930000 | USD | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
53371 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
276900 | shares | |
CY2013Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
43499000 | USD |
CY2013Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2130560 | shares |
CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2502190 | shares |
CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
13.51 | |
CY2013Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
15.82 | |
CY2013Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
38633000 | USD |
CY2013Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
1827646 | shares |
CY2013Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
30676000 | USD |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P5Y9M15D | ||
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y9M50D | ||
us-gaap |
Stock Issued1
StockIssued1
|
13000000 | USD | |
us-gaap |
Stock Issued1
StockIssued1
|
0 | USD | |
CY2013Q1 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
4715000 | shares |
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
595159 | shares | |
CY2013Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
121426000 | USD |
CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
44176000 | USD |
CY2013Q3 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | USD |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates in Preparation of Financial Statements</font></div><div style="line-height:120%;padding-top:6px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expense during the reporting periods. The most significant estimates used in these financial statements include the valuation of stock-based compensation expense, accounts receivable, inventories, goodwill, deferred revenue and equity instruments, the lives of property and equipment and intangible assets, as well as warranty and doubtful accounts allowance reserve calculations. Actual results may differ from those estimates.</font></div></div> | ||
CY2012Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
48041392 | shares |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
53786974 | shares | |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
47825136 | shares | |
CY2013Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
54458364 | shares |
podd |
Capital Lease Effective Interest Rate
CapitalLeaseEffectiveInterestRate
|
0.17 | ||
podd |
Capital Lease Term
CapitalLeaseTerm
|
P36M | ||
CY2012Q3 | podd |
Debt Instrument Stated Coupon Rate Interest Expense
DebtInstrumentStatedCouponRateInterestExpense
|
1549000 | USD |
podd |
Debt Instrument Stated Coupon Rate Interest Expense
DebtInstrumentStatedCouponRateInterestExpense
|
4356000 | USD | |
CY2013Q3 | podd |
Debt Instrument Stated Coupon Rate Interest Expense
DebtInstrumentStatedCouponRateInterestExpense
|
1347000 | USD |
podd |
Debt Instrument Stated Coupon Rate Interest Expense
DebtInstrumentStatedCouponRateInterestExpense
|
4647000 | USD | |
CY2012Q3 | podd |
Dollarequivalentofsharesissuedatconversion
Dollarequivalentofsharesissuedatconversion
|
0 | USD |
podd |
Dollarequivalentofsharesissuedatconversion
Dollarequivalentofsharesissuedatconversion
|
0 | USD | |
podd |
Dollarequivalentofsharesissuedatconversion
Dollarequivalentofsharesissuedatconversion
|
325000 | USD | |
CY2013Q3 | podd |
Dollarequivalentofsharesissuedatconversion
Dollarequivalentofsharesissuedatconversion
|
0 | USD |
podd |
Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
|
8657000 | USD | |
podd |
Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
|
16722000 | USD | |
CY2012Q1 | podd |
Maximum Annualauthorized Share Increaes
MaximumAnnualauthorizedShareIncreaes
|
725000 | shares |
CY2012Q4 | podd |
Number Of Customers With Greater Than Ten Percent Accounts Receivable Balance
NumberOfCustomersWithGreaterThanTenPercentAccountsReceivableBalance
|
2 | customer |
CY2013Q3 | podd |
Number Of Customers With Greater Than Ten Percent Accounts Receivable Balance
NumberOfCustomersWithGreaterThanTenPercentAccountsReceivableBalance
|
2 | customer |
CY2013Q3 | podd |
Number Of Financial Institution
NumberOfFinancialInstitution
|
2 | location |
CY2013Q3 | podd |
Number Of Inches Of Tubing In Conventional Insulin Pump
NumberOfInchesOfTubingInConventionalInsulinPump
|
42 | in |
CY2013Q3 | podd |
Number Of Single Source Suppliers
NumberOfSingleSourceSuppliers
|
1 | customer |
CY2012Q4 | podd |
Number Of Single Source Suppliers
NumberOfSingleSourceSuppliers
|
1 | customer |
CY2013Q1 | podd |
Proceeds Of Issuance Of Common Stock Net Of Expenses
ProceedsOfIssuanceOfCommonStockNetOfExpenses
|
92800000 | USD |
podd |
Product Warranty Term
ProductWarrantyTerm
|
P4Y | ||
podd |
Renewal Option Terms Additional Period
RenewalOptionTermsAdditionalPeriod
|
P5Y | ||
podd |
Return Period
ReturnPeriod
|
P45D | ||
podd |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures
|
0.16 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2013 | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2013-09-30 | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001145197 | ||
CY2013Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
54539340 | shares |
dei |
Entity Filer Category
EntityFilerCategory
|
Large Accelerated Filer | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
INSULET CORP | ||
dei |
Trading Symbol
TradingSymbol
|
PODD |